What Rhizome AI does
Rhizome AI is a regulatory intelligence platform for the life sciences that lets users query FDA, EMA, and other health-authority databases and receive answers with cited sources. It is designed to support regulatory research with traceable, document-backed responses rather than unsupported summaries.
Key capabilities
The platform indexes tens of millions of documents across regulatory and clinical datasets spanning multiple markets, including FDA guidance, clinical trials, and EMA assessment reports. Each answer cites specific source documents and pages, and the company emphasizes minimizing hallucinations through fine-tuning and inference-time checks. Typical questions include interpreting FDA guidance on emerging topics, understanding real-world evidence requirements, and comparing regulatory approaches across markets.
Who it's for
Rhizome AI serves regulatory affairs professionals at biotech and pharma companies, device and combination-product specialists, independent consultants, and enterprise pharmaceutical organizations that need fast, cited regulatory research.